Hills, S. A. & Diffley, J. F. DNA replication and oncogene-induced replicative stress. Curr. Biol.24, R435–R444 (2014). ArticleCASPubMed Google Scholar
Bartkova, J. et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature434, 864–870 (2005). CASPubMed Google Scholar
Gorgoulis, V. G. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature434, 907–913 (2005). References 4 and 5 provide compelling evidence for the connection between DNA replication stress and carcinogenesis from its early stages, to DNA damage and intra-S checkpoint activation. These results support the idea that DNA checkpoints act as a barrier to tumorigenesis and that their constitutive activation exerts a selective pressure on p53 mutations. CASPubMed Google Scholar
Bartkova, J. et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature444, 633–637 (2006). ArticleCASPubMed Google Scholar
Di Micco, R. et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature444, 638–642 (2006). ArticleCASPubMed Google Scholar
Durkin, S. G. et al. Replication stress induces tumor-like microdeletions in FHIT/FRA3B. Proc. Natl Acad. Sci. USA105, 246–251 (2008). ArticleCASPubMed Google Scholar
Bilousova, G., Marusyk, A., Porter, C. C., Cardiff, R. D. & DeGregori, J. Impaired DNA replication within progenitor cell pools promotes leukemogenesis. PLoS Biol.3, e401 (2005). ArticlePubMedPubMed CentralCAS Google Scholar
Aguilera, A. & Garcia-Muse, T. Causes of genome instability. Annu. Rev. Genet.47, 1–32 (2013). ArticleCASPubMed Google Scholar
Boos, D., Frigola, J. & Diffley, J. F. Activation of the replicative DNA helicase: breaking up is hard to do. Curr. Opin. Cell Biol.24, 423–430 (2012). ArticleCASPubMed Google Scholar
Blow, J. J., Ge, X. Q. & Jackson, D. A. How dormant origins promote complete genome replication. Trends Biochem. Sci.36, 405–414 (2011). ArticleCASPubMedPubMed Central Google Scholar
Shechter, D., Costanzo, V. & Gautier, J. ATR and ATM regulate the timing of DNA replication origin firing. Nature Cell Biol.6, 648–655 (2004). ArticleCASPubMed Google Scholar
Zou, L. & Elledge, S. J. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science300, 1542–1548 (2003). ArticleCASPubMed Google Scholar
Jazayeri, A. et al. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nature Cell Biol.8, 37–45 (2006). ArticleCASPubMed Google Scholar
Toledo, L. I. et al. ATR prohibits replication catastrophe by preventing global exhaustion of RPA. Cell155, 1088–1103 (2013). This study demonstrates that ATR-mediated origin inactivation in response to replicative checkpoint activation prevents nucleus-wide DNA breakage and thus the exhaustion of the nuclear pool of RPA. Importantly, RPA availability seems to considerably influence the magnitude of fork breakage. ArticleCASPubMed Google Scholar
O'Driscoll, M., Ruiz-Perez, V. L., Woods, C. G., Jeggo, P. A. & Goodship, J. A. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nature Genet.33, 497–501 (2003). ArticleCASPubMed Google Scholar
Murga, M. et al. Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors. Nature Struct. Mol. Biol.18, 1331–1335 (2011). ArticleCAS Google Scholar
Gilad, O. et al. Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner. Cancer Res.70, 9693–9702 (2010). ArticleCASPubMedPubMed Central Google Scholar
Koniaras, K., Cuddihy, A. R., Christopoulos, H., Hogg, A. & O'Connell, M. J. Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells. Oncogene20, 7453–7463 (2001). ArticleCASPubMed Google Scholar
Abdel-Fatah, T. M. et al. Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer. Mol. Oncol.9, 569–585 (2015). ArticleCASPubMed Google Scholar
Lopez-Contreras, A. J., Gutierrez-Martinez, P., Specks, J., Rodrigo-Perez, S. & Fernandez-Capetillo, O. An extra allele of Chk1 limits oncogene-induced replicative stress and promotes transformation. J. Exp. Med.209, 455–461 (2012). ArticleCASPubMedPubMed Central Google Scholar
Brown, E. J. & Baltimore, D. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev.14, 397–402 (2000). ArticleCASPubMedPubMed Central Google Scholar
Liu, Q. et al. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev.14, 1448–1459 (2000). ArticleCASPubMedPubMed Central Google Scholar
Tho, L. M., Libertini, S., Rampling, R., Sansom, O. & Gillespie, D. A. Chk1 is essential for chemical carcinogen-induced mouse skin tumorigenesis. Oncogene31, 1366–1375 (2012). ArticleCASPubMed Google Scholar
Vassileva, V., Millar, A., Briollais, L., Chapman, W. & Bapat, B. Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability. Cancer Res.62, 4095–4099 (2002). CASPubMed Google Scholar
Menoyo, A. et al. Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microsatellite instability. Cancer Res.61, 7727–7730 (2001). CASPubMed Google Scholar
Ibarra, A., Schwob, E. & Mendez, J. Excess MCM proteins protect human cells from replicative stress by licensing backup origins of replication. Proc. Natl Acad. Sci. USA105, 8956–8961 (2008). ArticleCASPubMedPubMed Central Google Scholar
Ge, X. Q., Jackson, D. A. & Blow, J. J. Dormant origins licensed by excess Mcm2-7 are required for human cells to survive replicative stress. Genes Dev.21, 3331–3341 (2007). ArticleCASPubMedPubMed Central Google Scholar
Kawabata, T. et al. Stalled fork rescue via dormant replication origins in unchallenged S phase promotes proper chromosome segregation and tumor suppression. Mol. Cell41, 543–553 (2011). ArticleCASPubMedPubMed Central Google Scholar
Shima, N. et al. A viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice. Nature Genet.39, 93–98 (2007). ArticleCASPubMed Google Scholar
Letessier, A. et al. Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site. Nature470, 120–123 (2011). ArticleCASPubMed Google Scholar
Ozeri-Galai, E. et al. Failure of origin activation in response to fork stalling leads to chromosomal instability at fragile sites. Mol. Cell43, 122–131 (2011). ArticleCASPubMed Google Scholar
Ekholm-Reed, S. et al. Deregulation of cyclin E in human cells interferes with prereplication complex assembly. J. Cell Biol.165, 789–800 (2004). ArticleCASPubMedPubMed Central Google Scholar
Li, A. & Blow, J. J. Cdt1 downregulation by proteolysis and geminin inhibition prevents DNA re-replication in Xenopus. EMBO J.24, 395–404 (2005). ArticleCASPubMed Google Scholar
Davidson, I. F., Li, A. & Blow, J. J. Deregulated replication licensing causes DNA fragmentation consistent with head-to-tail fork collision. Mol. Cell24, 433–443 (2006). ArticleCASPubMedPubMed Central Google Scholar
Vaziri, C. et al. A p53-dependent checkpoint pathway prevents rereplication. Mol. Cell11, 997–1008 (2003). ArticleCASPubMed Google Scholar
Liontos, M. et al. Deregulated overexpression of hCdt1 and hCdc6 promotes malignant behavior. Cancer Res.67, 10899–10909 (2007). ArticleCASPubMed Google Scholar
Aggarwal, P. et al. Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication. Genes Dev.21, 2908–2922 (2007). ArticleCASPubMedPubMed Central Google Scholar
Tardat, M. et al. The histone H4 Lys 20 methyltransferase PR-Set7 regulates replication origins in mammalian cells. Nature Cell Biol.12, 1086–1093 (2010). ArticleCASPubMed Google Scholar
Black, J. C. et al. KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors. Cell154, 541–555 (2013). ArticleCASPubMed Google Scholar
Dominguez-Sola, D. et al. Non-transcriptional control of DNA replication by c-Myc. Nature448, 445–451 (2007). This work demonstrates that MYC physically interacts with replication factors and participates in the control of DNA replication timing. Importantly, these new functions are totally independent of transcription. ArticleCASPubMed Google Scholar
Srinivasan, S. V., Dominguez-Sola, D., Wang, L. C., Hyrien, O. & Gautier, J. Cdc45 is a critical effector of myc-dependent DNA replication stress. Cell Rep.3, 1629–1639 (2013). ArticleCASPubMed Google Scholar
Frum, R. A. et al. The human oncoprotein MDM2 induces replication stress eliciting early intra-S-phase checkpoint response and inhibition of DNA replication origin firing. Nucleic Acids Res.42, 926–940 (2014). ArticleCASPubMed Google Scholar
Neelsen, K. J. et al. Deregulated origin licensing leads to chromosomal breaks by rereplication of a gapped DNA template. Genes Dev.27, 2537–2542 (2013). ArticleCASPubMedPubMed Central Google Scholar
Bester, A. C. et al. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell145, 435–446 (2011). This work shows that supplying nucleosides is sufficient to rescue the replication stress and DNA damage induced by oncogene activation and considerably decreases tumorigenesis. ArticleCASPubMedPubMed Central Google Scholar
Xie, M. et al. Bcl2 induces DNA replication stress by inhibiting ribonucleotide reductase. Cancer Res.74, 212–223 (2014). ArticleCASPubMed Google Scholar
Bartek, J., Lukas, C. & Lukas, J. Checking on DNA damage in S phase. Nature Rev. Mol. Cell Biol.5, 792–804 (2004). ArticleCAS Google Scholar
Gaillard, H., Herrera-Moyano, E. & Aguilera, A. Transcription-associated genome instability. Chem. Rev.113, 8638–8661 (2013). ArticleCASPubMed Google Scholar
Gottipati, P., Cassel, T. N., Savolainen, L. & Helleday, T. Transcription-associated recombination is dependent on replication in mammalian cells. Mol. Cell. Biol.28, 154–164 (2008). ArticleCASPubMed Google Scholar
Jones, R. M. et al. Increased replication initiation and conflicts with transcription underlie Cyclin E-induced replication stress. Oncogene32, 3744–3753 (2013). ArticleCASPubMed Google Scholar
Neelsen, K. J., Zanini, I. M., Herrador, R. & Lopes, M. Oncogenes induce genotoxic stress by mitotic processing of unusual replication intermediates. J. Cell Biol.200, 699–708 (2013). ArticleCASPubMedPubMed Central Google Scholar
Tuduri, S. et al. Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription. Nature Cell Biol.11, 1315–1324 (2009). ArticleCASPubMed Google Scholar
Dominguez-Sanchez, M. S., Barroso, S., Gomez-Gonzalez, B., Luna, R. & Aguilera, A. Genome instability and transcription elongation impairment in human cells depleted of THO/TREX. PLoS Genet.7, e1002386 (2011). ArticleCASPubMedPubMed Central Google Scholar
Paulsen, R. D. et al. A genome-wide siRNA screen reveals diverse cellular processes and pathways that mediate genome stability. Mol. Cell35, 228–239 (2009). ArticleCASPubMedPubMed Central Google Scholar
Helmrich, A., Ballarino, M. & Tora, L. Collisions between replication and transcription complexes cause common fragile site instability at the longest human genes. Mol. Cell44, 966–977 (2011). ArticleCASPubMed Google Scholar
Herrera-Moyano, E., Mergui, X., Garcia-Rubio, M. L., Barroso, S. & Aguilera, A. The yeast and human FACT chromatin-reorganizing complexes solve R-loop-mediated transcription-replication conflicts. Genes Dev.28, 735–748 (2014). ArticleCASPubMedPubMed Central Google Scholar
Bhatia, V. et al. BRCA2 prevents R-loop accumulation and associates with TREX-2 mRNA export factor PCID2. Nature511, 362–365 (2014). This work shows that BRCA2-depleted or BRCA2-deficient cancer cells accumulate R-loops and DNA damage, and that genome instability generated in such cells is partially dependent on R-loops. This work provides a novel role for BRCA2 in preventing or helping to remove R-loops and proposes that these R-loops are a major source of replication stress in cancer cells. ArticleCASPubMed Google Scholar
Sabo, A. et al. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis. Nature511, 488–492 (2014). ArticleCASPubMedPubMed Central Google Scholar
Brosh, R. M. Jr. DNA helicases involved in DNA repair and their roles in cancer. Nature Rev. Cancer13, 542–558 (2013). ArticleCAS Google Scholar
Thangavel, S. et al. Human RECQ1 and RECQ4 helicases play distinct roles in DNA replication initiation. Mol. Cell. Biol.30, 1382–1396 (2010). ArticleCASPubMedPubMed Central Google Scholar
Popuri, V., Croteau, D. L., Brosh, R. M. Jr & Bohr, V. A. RECQ1 is required for cellular resistance to replication stress and catalyzes strand exchange on stalled replication fork structures. Cell Cycle11, 4252–4265 (2012). ArticleCASPubMedPubMed Central Google Scholar
Saponaro, M. et al. RECQL5 controls transcript elongation and suppresses genome instability associated with transcription stress. Cell157, 1037–1049 (2014). ArticleCASPubMedPubMed Central Google Scholar
Pichierri, P., Franchitto, A., Mosesso, P. & Palitti, F. Werner's syndrome protein is required for correct recovery after replication arrest and DNA damage induced in S-phase of cell cycle. Mol. Biol. Cell12, 2412–2421 (2001). ArticleCASPubMedPubMed Central Google Scholar
Davies, S. L., North, P. S. & Hickson, I. D. Role for BLM in replication-fork restart and suppression of origin firing after replicative stress. Nature Struct. Mol. Biol.14, 677–679 (2007). ArticleCAS Google Scholar
Machwe, A., Karale, R., Xu, X., Liu, Y. & Orren, D. K. The Werner and Bloom syndrome proteins help resolve replication blockage by converting (regressed) holliday junctions to functional replication forks. Biochemistry50, 6774–6788 (2011). ArticleCASPubMed Google Scholar
Schwartz, E. K. & Heyer, W. D. Processing of joint molecule intermediates by structure-selective endonucleases during homologous recombination in eukaryotes. Chromosoma120, 109–127 (2011). ArticleCASPubMedPubMed Central Google Scholar
Hanada, K. et al. The structure-specific endonuclease Mus81 contributes to replication restart by generating double-strand DNA breaks. Nature Struct. Mol. Biol.14, 1096–1104 (2007). ArticleCAS Google Scholar
Fugger, K. et al. FBH1 co-operates with MUS81 in inducing DNA double-strand breaks and cell death following replication stress. Nature Commun.4, 1–8 (2013). ArticleCAS Google Scholar
Jeong, Y. T. et al. FBH1 promotes DNA double-strand breakage and apoptosis in response to DNA replication stress. J. Cell Biol.200, 141–149 (2013). ArticleCASPubMedPubMed Central Google Scholar
Murfuni, I. et al. The WRN and MUS81 proteins limit cell death and genome instability following oncogene activation. Oncogene32, 610–620 (2013). ArticleCASPubMed Google Scholar
Luebben, S. W., Kawabata, T., Johnson, C. S., O'Sullivan, M. G. & Shima, N. A concomitant loss of dormant origins and FANCC exacerbates genome instability by impairing DNA replication fork progression. Nucleic Acids Res.42, 5605–5615 (2014). ArticleCASPubMedPubMed Central Google Scholar
Ciccia, A., McDonald, N. & West, S. C. Structural and functional relationships of the XPF/MUS81 family of proteins. Annu. Rev. Biochem.77, 259–287 (2008). ArticleCASPubMed Google Scholar
Garcia-Higuera, I. et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell7, 249–262 (2001). ArticleCASPubMed Google Scholar
Wang, X., Andreassen, P. R. & D'Andrea, A. D. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol. Cell. Biol.24, 5850–5862 (2004). ArticleCASPubMedPubMed Central Google Scholar
Murina, O. et al. FANCD2 and CtIP cooperate to repair DNA interstrand crosslinks. Cell Rep.7, 1030–1038 (2014). ArticleCASPubMed Google Scholar
Adamo, A. et al. Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia. Mol. Cell39, 25–35 (2010). ArticleCASPubMed Google Scholar
Lomonosov, M., Anand, S., Sangrithi, M., Davies, R. & Venkitaraman, A. R. Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein. Genes Dev.17, 3017–3022 (2003). ArticleCASPubMedPubMed Central Google Scholar
Petermann, E., Orta, M. L., Issaeva, N., Schultz, N. & Helleday, T. Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. Mol. Cell37, 492–502 (2010). ArticleCASPubMedPubMed Central Google Scholar
Willis, N. A. et al. BRCA1 controls homologous recombination at Tus/Ter-stalled mammalian replication forks. Nature510, 556–559 (2014). ArticleCASPubMedPubMed Central Google Scholar
Schlacher, K. et al. Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11. Cell145, 529–542 (2011). ArticleCASPubMedPubMed Central Google Scholar
Schlacher, K., Wu, H. & Jasin, M. A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2. Cancer Cell22, 106–116 (2012). ArticleCASPubMedPubMed Central Google Scholar
Lossaint, G. et al. FANCD2 binds MCM proteins and controls replisome function upon activation of S phase checkpoint signaling. Mol. Cell51, 678–690 (2013). ArticleCASPubMed Google Scholar
Hakem, R. et al. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell85, 1009–1023 (1996). ArticleCASPubMed Google Scholar
Xu, X. et al. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Nature Genet.28, 266–271 (2001). ArticleCASPubMed Google Scholar
Jonkers, J. et al. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nature Genet.29, 418–425 (2001). ArticleCASPubMed Google Scholar
Houghtaling, S. et al. Heterozygosity for p53 (Trp53+/−) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice. Cancer Res.65, 85–91 (2005). CASPubMed Google Scholar
Hill, S. J. et al. Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage. Genes Dev.28, 1957–1975 (2014). ArticleCASPubMedPubMed Central Google Scholar
Hatchi, E. et al. BRCA1 recruitment to transcriptional pause sites is required for R-loop-driven DNA damage repair. Mol. Cell57, 636–647 (2015). ArticleCASPubMedPubMed Central Google Scholar
Klein, H. L. The consequences of Rad51 overexpression for normal and tumor cells. DNA Repair (Amst.)7, 686–693 (2008). ArticleCAS Google Scholar
Lange, S. S., Takata, K. & Wood, R. D. DNA polymerases and cancer. Nature Rev. Cancer11, 96–110 (2011). ArticleCAS Google Scholar
Pan, Q., Fang, Y., Xu, Y., Zhang, K. & Hu, X. Down-regulation of DNA polymerases κ, η, ι, and ζ in human lung, stomach, and colorectal cancers. Cancer Lett.217, 139–147 (2005). ArticleCASPubMed Google Scholar
Buisson, R. et al. Breast cancer proteins PALB2 and BRCA2 stimulate polymerase η in recombination-associated DNA synthesis at blocked replication forks. Cell Rep.6, 553–564 (2014). ArticleCASPubMedPubMed Central Google Scholar
McCulloch, S. D. et al. Preferential _cis_-syn thymine dimer bypass by DNA polymerase η occurs with biased fidelity. Nature428, 97–100 (2004). ArticleCASPubMed Google Scholar
Rey, L. et al. Human DNA polymerase η is required for common fragile site stability during unperturbed DNA replication. Mol. Cell. Biol.29, 3344–3354 (2009). ArticleCASPubMedPubMed Central Google Scholar
Lange, S. S., Wittschieben, J. P. & Wood, R. D. DNA polymerase ζ is required for proliferation of normal mammalian cells. Nucleic Acids Res.40, 4473–4482 (2012). ArticleCASPubMedPubMed Central Google Scholar
Mailand, N., Gibbs-Seymour, I. & Bekker-Jensen, S. Regulation of PCNA-protein interactions for genome stability. Nature Rev. Mol. Cell Biol.14, 269–282 (2013). ArticleCAS Google Scholar
Lin, J. R., Zeman, M. K., Chen, J. Y., Yee, M. C. & Cimprich, K. A. SHPRH and HLTF act in a damage-specific manner to coordinate different forms of postreplication repair and prevent mutagenesis. Mol. Cell42, 237–249 (2011). ArticleCASPubMedPubMed Central Google Scholar
Motegi, A. et al. Polyubiquitination of proliferating cell nuclear antigen by HLTF and SHPRH prevents genomic instability from stalled replication forks. Proc. Natl Acad. Sci. USA105, 12411–12416 (2008). ArticleCASPubMedPubMed Central Google Scholar
Millikin, D., Meese, E., Vogelstein, B., Witkowski, C. & Trent, J. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res.51, 5449–5453 (1991). CASPubMed Google Scholar
Bouwman, P. et al. 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nature Struct. Mol. Biol.17, 688–695 (2010). ArticleCAS Google Scholar
Bunting, S. F. et al. 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell141, 243–254 (2010). Together, references 110 and 111 demonstrate that loss of the NHEJ factor 53BP1 restores error-free repair by HR in BRCA1-deficient cells. These results indicate that 53BP1 and BRCA1 have crucial roles in the regulation of the choice between the NHEJ and HR repair pathways. ArticleCASPubMedPubMed Central Google Scholar
Thorslund, T. et al. The breast cancer tumor suppressor BRCA2 promotes the specific targeting of RAD51 to single-stranded DNA. Nature Struct. Mol. Biol.17, 1263–1265 (2010). ArticleCAS Google Scholar
Saeki, H. et al. Suppression of the DNA repair defects of BRCA2-deficient cells with heterologous protein fusions. Proc. Natl Acad. Sci. USA103, 8768–8773 (2006). ArticleCASPubMedPubMed Central Google Scholar
Bunting, S. F. & Nussenzweig, A. End-joining, translocations and cancer. Nature Rev. Cancer13, 443–454 (2013). ArticleCAS Google Scholar
Bolderson, E. et al. Human single-stranded DNA binding protein 1 (hSSB1/NABP2) is required for the stability and repair of stalled replication forks. Nucleic Acids Res.42, 6326–6336 (2014). ArticleCASPubMedPubMed Central Google Scholar
Shi, W. et al. Essential developmental, genomic stability, and tumour suppressor functions of the mouse orthologue of hSSB1/NABP2. PLoS Genet.9, e1003298 (2013). ArticleCASPubMedPubMed Central Google Scholar
Wang, Y. et al. Mutation in Rpa1 results in defective DNA double-strand break repair, chromosomal instability and cancer in mice. Nature Genet.37, 750–755 (2005). ArticleCASPubMed Google Scholar
Wechsler, T., Newman, S. & West, S. C. Aberrant chromosome morphology in human cells defective for Holliday junction resolution. Nature471, 642–646 (2011). ArticleCASPubMedPubMed Central Google Scholar
Gisselsson, D. et al. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc. Natl Acad. Sci. USA97, 5357–5362 (2000). ArticleCASPubMedPubMed Central Google Scholar
Janssen, A., van der Burg, M., Szuhai, K., Kops, G. J. & Medema, R. H. Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science333, 1895–1898 (2011). ArticleCASPubMed Google Scholar
Wilhelm, T. et al. Spontaneous slow replication fork progression elicits mitosis alterations in homologous recombination-deficient mammalian cells. Proc. Natl Acad. Sci. USA111, 763–768 (2014). ArticleCASPubMed Google Scholar
Thompson, S. L. & Compton, D. A. Chromosome missegregation in human cells arises through specific types of kinetochore-microtubule attachment errors. Proc. Natl Acad. Sci. USA108, 17974–17978 (2011). ArticleCASPubMedPubMed Central Google Scholar
Stephens, P. J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell144, 27–40 (2011). ArticleCASPubMedPubMed Central Google Scholar
Dick, F. A. & Rubin, S. M. Molecular mechanisms underlying RB protein function. Nature Rev. Mol. Cell Biol.14, 297–306 (2013). ArticleCAS Google Scholar
Manning, A. L. et al. Suppression of genome instability in pRB-deficient cells by enhancement of chromosome cohesion. Mol. Cell53, 993–1004 (2014). ArticleCASPubMedPubMed Central Google Scholar
Chan, K. L., North, P. S. & Hickson, I. D. BLM is required for faithful chromosome segregation and its localization defines a class of ultrafine anaphase bridges. EMBO J.26, 3397–3409 (2007). ArticleCASPubMedPubMed Central Google Scholar
Chan, K. L., Palmai-Pallag, T., Ying, S. & Hickson, I. D. Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. Nature Cell Biol.11, 753–760 (2009). ArticleCASPubMed Google Scholar
Naim, V. & Rosselli, F. The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities. Nature Cell Biol.11, 761–768 (2009). References 130 and 131 provide evidence supporting the idea that unresolved replication or recombination intermediates resulting from replication stress remain interlinked through ultra-fine DNA bridges as cells go through mitosis. These studies show that the FA and Bloom pathways collaborate to avoid or resolve such situations and to promote accurate chromosome segregation. ArticleCASPubMed Google Scholar
Ying, S. et al. MUS81 promotes common fragile site expression. Nature Cell Biol.15, 1001–1007 (2013). ArticleCASPubMed Google Scholar
Naim, V., Wilhelm, T., Debatisse, M. & Rosselli, F. ERCC1 and MUS81-EME1 promote sister chromatid separation by processing late replication intermediates at common fragile sites during mitosis. Nature Cell Biol.15, 1008–1015 (2013). ArticleCASPubMed Google Scholar
Burrell, R. A. et al. Replication stress links structural and numerical cancer chromosomal instability. Nature494, 492–496 (2013). In this study, analysis of colorectal cancer cells with cancer chromosomal instability revealed that they undergo replication stress and that this replication stress contributes to both structural abnormalities and chromosome missegregation. ArticleCASPubMedPubMed Central Google Scholar
Gad, H. et al. MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool. Nature508, 215–221 (2014). ArticleCASPubMed Google Scholar
Steckel, M. et al. Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies. Cell Res.22, 1227–1245 (2012). ArticleCASPubMedPubMed Central Google Scholar
Zimmerman, K. M., Jones, R. M., Petermann, E. & Jeggo, P. A. Diminished origin-licensing capacity specifically sensitizes tumor cells to replication stress. Mol. Cancer Res.11, 370–380 (2013). ArticleCASPubMedPubMed Central Google Scholar
Lin, J. J., Milhollen, M. A., Smith, P. G., Narayanan, U. & Dutta, A. NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells. Cancer Res.70, 10310–10320 (2010). ArticleCASPubMedPubMed Central Google Scholar
Wang, Q. et al. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. J. Natl Cancer Inst.88, 956–965 (1996). ArticleCASPubMed Google Scholar
Fishler, T. et al. Genetic instability and mammary tumor formation in mice carrying mammary-specific disruption of Chk1 and p53. Oncogene29, 4007–4017 (2010). ArticleCASPubMedPubMed Central Google Scholar
Kawasumi, M. et al. Protection from UV-induced skin carcinogenesis by genetic inhibition of the ataxia telangiectasia and Rad3-related (ATR) kinase. Proc. Natl Acad. Sci. USA108, 13716–13721 (2011). ArticleCASPubMedPubMed Central Google Scholar
Reaper, P. M. et al. Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR. Nature Chem. Biol.7, 428–430 (2011). ArticleCAS Google Scholar
Toledo, L. I. et al. A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations. Nature Struct. Mol. Biol.18, 721–727 (2011). ArticleCAS Google Scholar
Charrier, J. D. et al. Discovery of potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase as potential anticancer agents. J. Med. Chem.54, 2320–2330 (2011). ArticleCASPubMed Google Scholar
Bryant, H. E. et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature434, 913–917 (2005). ArticleCASPubMed Google Scholar
Farmer, H. et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature434, 917–921 (2005). ArticleCASPubMed Google Scholar
Michels, J., Vitale, I., Saparbaev, M., Castedo, M. & Kroemer, G. Predictive biomarkers for cancer therapy with PARP inhibitors. Oncogene33, 3894–3907 (2014). ArticleCASPubMed Google Scholar
Nicolay, N. H., Helleday, T. & Sharma, R. A. Biological relevance of DNA polymerase β and translesion synthesis polymerases to cancer and its treatment. Curr. Mol. Pharmacol.5, 54–67 (2012). ArticleCASPubMed Google Scholar
Zucca, E. et al. Silencing of human DNA polymerase λ causes replication stress and is synthetically lethal with an impaired S phase checkpoint. Nucleic Acids Res.41, 229–241 (2013). ArticleCASPubMed Google Scholar
Costantino, L. et al. Break-induced replication repair of damaged forks induces genomic duplications in human cells. Science343, 88–91 (2014). ArticleCASPubMed Google Scholar
Masai, H., Matsumoto, S., You, Z., Yoshizawa-Sugata, N. & Oda, M. Eukaryotic chromosome DNA replication: where, when, and how? Annu. Rev. Biochem.79, 89–130 (2010). ArticleCASPubMed Google Scholar
Durkin, S. G. & Glover, T. W. Chromosome fragile sites. Annu. Rev. Genet.41, 169–192 (2007). ArticleCASPubMed Google Scholar
Debatisse, M., Le Tallec, B., Letessier, A., Dutrillaux, B. & Brison, O. Common fragile sites: mechanisms of instability revisited. Trends Genet.28, 22–32 (2012). ArticleCASPubMed Google Scholar
Lahiri, M., Gustafson, T. L., Majors, E. R. & Freudenreich, C. H. Expanded CAG repeats activate the DNA damage checkpoint pathway. Mol. Cell15, 287–293 (2004). ArticleCASPubMed Google Scholar
Casper, A. M., Nghiem, P., Arlt, M. F. & Glover, T. W. ATR regulates fragile site stability. Cell111, 779–789 (2002). ArticleCASPubMed Google Scholar
Yunis, J. J. & Soreng, A. L. Constitutive fragile sites and cancer. Science226, 1199–1204 (1984). ArticleCASPubMed Google Scholar
Burrow, A. A., Williams, L. E., Pierce, L. C. & Wang, Y. H. Over half of breakpoints in gene pairs involved in cancer-specific recurrent translocations are mapped to human chromosomal fragile sites. BMC Genomicshttp://dx.doi.org/10.1186/1471-2164-10-59 (2009).
Tsantoulis, P. K. et al. Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study. Oncogene27, 3256–3264 (2008). ArticleCASPubMed Google Scholar
Gandhi, M., Dillon, L. W., Pramanik, S., Nikiforov, Y. E. & Wang, Y. H. DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells. Oncogene29, 2272–2280 (2010). ArticleCASPubMedPubMed Central Google Scholar
Hellman, A. et al. A role for common fragile site induction in amplification of human oncogenes. Cancer Cell1, 89–97 (2002). ArticleCASPubMed Google Scholar
Blumrich, A. et al. The FRA2C common fragile site maps to the borders of MYCN amplicons in neuroblastoma and is associated with gross chromosomal rearrangements in different cancers. Hum. Mol. Genet.20, 1488–1501 (2011). ArticleCASPubMed Google Scholar
Ohta, M. et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell84, 587–597 (1996). ArticleCASPubMed Google Scholar
Corbin, S. et al. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors. Cancer Res.62, 3477–3484 (2002). CASPubMed Google Scholar
Gong, Y. et al. Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins. Nature Genet.46, 588–594 (2014). ArticleCASPubMed Google Scholar
Le Tallec, B. et al. Molecular profiling of common fragile sites in human fibroblasts. Nature Struct. Mol. Biol.18, 1421–1423 (2011). ArticleCAS Google Scholar
Le Tallec, B. et al. Common fragile site profiling in epithelial and erythroid cells reveals that most recurrent cancer deletions lie in fragile sites hosting large genes. Cell Rep.4, 420–428 (2013). ArticleCASPubMed Google Scholar
Barlow, J. H. et al. Identification of early replicating fragile sites that contribute to genome instability. Cell152, 620–632 (2013). This work identifies a novel type of fragile site in B lymphocytes. These sites replicate early, in contrast to common fragile sites, and colocalize with highly expressed gene clusters. Importantly, many recurrent amplifications and deletions found in human lymphomas map to these fragile genomic sites. ArticleCASPubMedPubMed Central Google Scholar
Ogrunc, M. et al. Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation. Cell Death Differ.21, 998–1012 (2014). ArticleCASPubMedPubMed Central Google Scholar
Arentson, E. et al. Oncogenic potential of the DNA replication licensing protein CDT1. Oncogene21, 1150–1158 (2002). ArticleCASPubMed Google Scholar
Seo, J. et al. Cdt1 transgenic mice develop lymphoblastic lymphoma in the absence of p53. Oncogene24, 8176–8186 (2005). ArticleCASPubMed Google Scholar
Pruitt, S. C., Bailey, K. J. & Freeland, A. Reduced Mcm2 expression results in severe stem/progenitor cell deficiency and cancer. Stem Cells25, 3121–3132 (2007). ArticleCASPubMed Google Scholar
Kucherlapati, M. et al. Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progression. Proc. Natl Acad. Sci. USA99, 9924–9929 (2002). ArticleCASPubMedPubMed Central Google Scholar
Zheng, L. et al. Fen1 mutations result in autoimmunity, chronic inflammation and cancers. Nature Med.13, 812–819 (2007). ArticleCASPubMed Google Scholar
Larsen, E. et al. Early-onset lymphoma and extensive embryonic apoptosis in two domain-specific Fen1 mice mutants. Cancer Res.68, 4571–4579 (2008). ArticleCASPubMed Google Scholar
Xu, X. et al. Broad overexpression of ribonucleotide reductase genes in mice specifically induces lung neoplasms. Cancer Res.68, 2652–2660 (2008). ArticleCASPubMedPubMed Central Google Scholar
Rahman, L. et al. Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme. Cancer Cell5, 341–351 (2004). ArticleCASPubMed Google Scholar
Chen, M. et al. Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas. Oncogene26, 4817–4824 (2007). ArticleCASPubMed Google Scholar
Fang, Y. et al. ATR functions as a gene dosage-dependent tumor suppressor on a mismatch repair-deficient background. EMBO J.23, 3164–3174 (2004). ArticleCASPubMedPubMed Central Google Scholar
Barlow, C. et al. _Atm_-deficient mice: a paradigm of ataxia telangiectasia. Cell86, 159–171 (1996). ArticleCASPubMed Google Scholar
Xu, Y. et al. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev.10, 2411–2422 (1996). ArticleCASPubMed Google Scholar
Elson, A. et al. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc. Natl Acad. Sci. USA93, 13084–13089 (1996). ArticleCASPubMedPubMed Central Google Scholar
Stracker, T. H., Couto, S. S., Cordon-Cardo, C., Matos, T. & Petrini, J. H. Chk2 suppresses the oncogenic potential of DNA replication-associated DNA damage. Mol. Cell31, 21–32 (2008). ArticleCASPubMedPubMed Central Google Scholar
Lin, Q. et al. Increased susceptibility to UV-induced skin carcinogenesis in polymerase η-deficient mice. Cancer Res.66, 87–94 (2006). ArticleCASPubMed Google Scholar
Hu, Y. et al. RECQL5/Recql5 helicase regulates homologous recombination and suppresses tumor formation via disruption of Rad51 presynaptic filaments. Genes Dev.21, 3073–3084 (2007). ArticleCASPubMedPubMed Central Google Scholar
Mann, M. B. et al. Defective sister-chromatid cohesion, aneuploidy and cancer predisposition in a mouse model of type II Rothmund-Thomson syndrome. Hum. Mol. Genet.14, 813–825 (2005). ArticleCASPubMed Google Scholar
Luo, G. et al. Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nature Genet.26, 424–429 (2000). ArticleCASPubMed Google Scholar
Pamidi, A. et al. Functional interplay of p53 and Mus81 in DNA damage responses and cancer. Cancer Res.67, 8527–8535 (2007). ArticleCASPubMed Google Scholar
Hodskinson, M. R. et al. Mouse SLX4 is a tumor suppressor that stimulates the activity of the nuclease XPF-ERCC1 in DNA crosslink repair. Mol. Cell54, 472–484 (2014). ArticleCASPubMedPubMed Central Google Scholar
Xu, X. et al. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nature Genet.22, 37–43 (1999). ArticleCASPubMed Google Scholar
Ludwig, T., Fisher, P., Ganesan, S. & Efstratiadis, A. Tumorigenesis in mice carrying a truncating Brca1 mutation. Genes Dev.15, 1188–1193 (2001). ArticleCASPubMedPubMed Central Google Scholar
Connor, F. et al. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nature Genet.17, 423–430 (1997). ArticleCASPubMed Google Scholar
Houghtaling, S. et al. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev.17, 2021–2035 (2003). ArticleCASPubMedPubMed Central Google Scholar